Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - EYEGATE PHARMACEUTICALS INC | v405650_ex32-1.htm |
| EX-21.1 - EXHIBIT 21.1 - EYEGATE PHARMACEUTICALS INC | v405650_ex21-1.htm |
| EX-31.1 - EXHIBIT 31.1 - EYEGATE PHARMACEUTICALS INC | v405650_ex31-1.htm |
| 10-K - 10-K - EYEGATE PHARMACEUTICALS INC | v405650_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement of EyeGate Pharmaceuticals, Inc. on Form S-8 (No. 333-202207) of our report dated March 31, 2015, on our audits of the consolidated financial statements as of December 31, 2014 and 2013 and for each of the years in the two-year period ended December 31, 2014, which report is included in this Annual Report on Form 10-K, to be filed on or about March 31, 2015. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company's ability to continue as a going concern.
/s/ EISNERAMPER LLP
New York, New York
March 31, 2015